COFCO Biotechnology Hits Day High with Strong 3.82% Intraday Surge

COFCO Biotechnology Co., Ltd., a prominent player in the specialty chemicals sector, has experienced a notable increase of 3.82% on March 12, 2026, reaching an intraday high of CNY 7.85. This performance stands in contrast to the China Shanghai Composite, which saw a slight decline of 0.1% on the same day. Over the past week, COFCO Biotechnology has shown a robust performance with an 11.58% increase, and its monthly performance reflects a significant rise of 14.95%. Year-to-date, the stock has gained 31.89%, outperforming the broader market index, which has only increased by 4.04%. Despite these positive short-term trends, the company has faced challenges in long-term growth, with net sales declining at an annual rate of 1.47% over the last five years. However, COFCO has reported positive results for the last four consecutive quarters, with a notable increase in net profit and operating cash flow. The company maintains a market capitalization of CNY 12,048 million and a price-to-earnings ratio of 129.00, indicating a complex financial landscape as it navigates its position in the market.